However, the molecular subgroup in which DNMT3A mutations are found significantly associated to a worse outcome varies across studies, most reports showing that the poor prognostic impact of DNMT3A mutations was most obvious in CN-AML with NPM1/FLT3 non-favorable genotypes [11, 23–26]. Here, FLT3 is linked to acute myeloid leukemia.